Last update: May 7, 2019
Decreased level of risk
New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was High Risk probable, is now set to Low Risk probable.
Level of risk reviewed on May 7, 2019
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Ergot derivative alkaloid. It may inhibit prolactin secretion.
It is used together with other substances (e.g. caffeine, which is a cause of anxiety). Multiple drug association is not recommended.
On latest update relevant data on breastfeeding was not found.
Sumatriptan which is a drug with well known low excretion into breast milk should be an alternative treatment for Migraine.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM